Because infection of erythroid cells with SFFV mimics some of the effects of Epo on those cells, numerous investigations logically focused on determining whether the unique envelope glycoprotein of SFFV, which is the sole determinant of its pathogenicity, was able to activate signaling molecules regulated by the interaction of Epo with its dimeric cell surface receptor. The gene discussed is EPO; the disease is infection.